Affiliation:
1. Department of Clinical Neuroscience, Karolinska Institutet , Stockholm 17165 , Sweden
2. Department of Neurobiology , Care Sciences and Society, , Stockholm 17165 , Sweden
3. Karolinska Institutet , Care Sciences and Society, , Stockholm 17165 , Sweden
4. Department of Physics, University of Gothenburg , Gothenburg 40530 , Sweden
Abstract
Abstract
Increasing evidence suggests that patients with Alzheimer’s disease present alterations in functional connectivity but previous results have not always been consistent. One of the reasons that may account for this inconsistency is the lack of consideration of temporal dynamics. To address this limitation, here we studied the dynamic modular organization on resting-state functional magnetic resonance imaging across different stages of Alzheimer’s disease using a novel multilayer brain network approach. Participants from preclinical and clinical Alzheimer’s disease stages were included. Temporal multilayer networks were used to assess time-varying modular organization. Logistic regression models were employed for disease stage discrimination, and partial least squares analyses examined associations between dynamic measures with cognition and pathology. Temporal multilayer functional measures distinguished all groups, particularly preclinical stages, overcoming the discriminatory power of risk factors such as age, sex, and APOE ϵ4 carriership. Dynamic multilayer functional measures exhibited strong associations with cognition as well as amyloid and tau pathology. Dynamic multilayer functional connectivity shows promise as a functional imaging biomarker for both early- and late-stage Alzheimer’s disease diagnosis.
Funder
Swedish Research Council
Center for Medical Innovation
Swedish Alzheimer Foundation
Senior Researcher Position Karolinska Institute
Swedish Brain Foundation
Gamla Tjänarinnor
KI foundations
Alzheimer's Disease Neuroimaging Initiative
National Institutes of Health
Department of Defense
National Institute on Aging
National Institute of Biomedical Imaging and Bioengineering
Alzheimer's Association
Alzheimer's Drug Discovery Foundation
BioClinica, Inc.
Biogen Idec Inc.
Bristol-Myers Squibb Company
Eisai Inc.
Elan Pharmaceuticals, Inc.
Eli Lilly and Company
GEHealthcare
Johnson and Johnson Pharmaceutical Research and Development LLC.
Medpace, Inc.
Publisher
Oxford University Press (OUP)
Reference66 articles.
1. State-switching and high-order spatiotemporal organization of dynamic functional connectivity are disrupted by Alzheimer’s disease;Arbabyazd;Netw Neurosci,2023
2. The insight ToolKit image registration framework;Avants;Front Neuroinform,2014
3. Hierarchical organization of human cortical networks in health and schizophrenia;Bassett;J Neurosci,2008
4. Dynamic reconfiguration of human brain networks during learning;Bassett;PNAS,2011
5. Learning-induced autonomy of sensorimotor systems;Bassett;Nat Neurosci,2015